Parasites, Hosts and Diseases

  • 제60권1호
  • /
  • Pages.15-23
  • /
  • 2022
  • /
  • 2982-5164(pISSN)
  • /
  • 1738-0006(eISSN)
대한기생충학·열대의학회 (The Korea Society for Parasitology and Tropical Medicine)
권호 표지
DOI QR코드

DOI QR Code

Prevalence of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency among Malaria Patients in Southern Thailand: 8 Years Retrospective Study

  • 투고 : 2021.08.27
  • 심사 : 2021.12.22
  • 발행 : 2022.02.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Erythrocytes deficient in glucose-6-phosphate dehydrogenase (G6PD) is more susceptible to oxidative damage from free radical derived compounds. The hemolysis triggered by oxidative agents such as primaquine (PQ) is used for the radical treatment of hypnozoites of P. vivax. Testing of G6PD screening before malaria treatment is not a common practice in Thailand, which poses patients at risk of hemolysis. This retrospective study aimed to investigate the prevalence of G6PD in malaria patients who live in Southern Thailand. Eight hundred eighty-one malaria patients were collected for 8-year from 2012 to 2019, including 785 (89.1%) of P. vivax, 61 (6.9%) of P. falciparum, 27 (3.1%) of P. knowlesi, and 8 (0.9%) of mixed infections. The DiaPlexC genotyping kit (Asian type) and PCR-RFLP were employed to determine the G6PD variants. The result showed that 5 different types of G6PD variants were identified in 26 cases (2.9%); 12/26 (46.2%) had Mahidol (487G>A) and 11/26 (42.3%) had Viangchan (871G>A) variants, while the rest had Kaiping (1388G>A), Union (1360C>T), and Mediterranean (563C>T) variants. G6PD Songklanagarind (196T>A) variant was not found in the study. Our result did not show a significant difference in the malaria parasite densities in patients between G6PD-deficient and G6PD-normal groups. According to our findings, testing G6PD deficiency and monitoring the potential PQ toxicity in patients who receive PQ are highly recommended.

키워드

과제정보

Funding for this study was provided by a grant from Prince of Songkla University, contract no. MET6302044S and PSU-Ph.D. Scholarship contract no. PSU_PHD2562-004.

참고문헌

  1. Luzzatto L, Nannelli C, Notaro R. Glucose-6-phosphate dehydrogenase deficiency. Hematol Oncol Clin North Am 2016; 30: 373-393. https://doi.org/10.1016/j.hoc.2015.11.006
  2. Gomez-Manzo S, Marcial-Quino J, Ortega-Cuellar D, SerranoPosada H, Gonzalez-Valdez A, Vanoye-Carlo A, HernandezOchoa B, Sierra-Palacios E, Castillo-Villanueva A, Reyes-Vivas H. Functional and biochemical analysis of glucose-6-phosphate dehydrogenase (G6PD) variants: elucidating the molecular basis of G6PD deficiency. Catalysts 2017; 7: 135. https://doi.org/10.3390/catal7050135
  3. Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet 2008; 371: 64-74. https://doi.org/10.1016/S0140-6736(08)60073-2
  4. Frank JE. Diagnosis and management of G6PD deficiency. Am Fam Physician 2005; 72: 1277-1282.
  5. Howes RE, Dewi M, Piel FB, Monteiro WM, Battle KE, Messina JP, Sakuntabhai A, Satyagraha AW, Williams TN, Baird JK, Hay SI. Spatial distribution of G6PD deficiency variants across malaria-endemic regions. Malar J 2013; 12: 418. https://doi.org/10.1186/1475-2875-12-418
  6. Howes RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, Dewi M, Hogg MM, Battle KE, Padilla CD, Baird JK, Hay SI. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med 2012; 9: e1001339. https://doi.org/10.1371/journal.pmed.1001339
  7. Pathak V, Colah R, Ghosh K. Effect of inherited red cell defects on growth of Plasmodium falciparum: An in vitro study. Indian J Med Res 2018; 147: 102-109. https://doi.org/10.4103/ijmr.IJMR_1146_16
  8. Cappadoro M, Giribaldi G, O'Brien E, Turrini F, Mannu F, Ulliers D, Simula G, Luzzatto L, Arese P. Early phagocytosis of glucose6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency. Blood 1998; 92: 2527-2534. https://doi.org/10.1182/blood.V92.7.2527
  9. Guindo A, Fairhurst RM, Doumbo OK, Wellems TE, Diallo DA. X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria. PLoS Med 2007; 4: e66. https://doi.org/10.1371/journal.pmed.0040066
  10. Uyoga S, Ndila CM, Macharia AW, Nyutu G, Shah S, Peshu N, Clarke GM, Kwiatkowski DP, Rockett KA, Williams TN. Glucose6-phosphate dehydrogenase deficiency and the risk of malaria and other diseases in children in Kenya: a case-control and a cohort study. Lancet Haematol 2015; 2: 437-444. https://doi.org/10.1016/S2352-3026(15)00152-0
  11. Recht J, Ashley EA, White NJ. Use of primaquine and glucose6-phosphate dehydrogenase deficiency testing: divergent policies and practices in malaria endemic countries. PLoS Negl Trop Dis 2018; 12: e0006230. https://doi.org/10.1371/journal.pntd.0006230
  12. World Health Organization. Testing for G6PD deficiency for safe use of primaquine in radical cure of P. vivax and P. ovale: Policy brief. Geneva, Switzerland. World Health Organization. 2016. https://apps.who.int/iris/handle/10665/250297
  13. USAID. President's Malaria Initiative: Thailand, Lao PDR and Regional Abbreviated Malaria Operation Plan FY 2019 [Internet]. United States Agency for International Development; [cited 2022 Jan 22]. Available from: https://d1u4sg1s9ptc4z.cloudfront.net/uploads/2021/03/fy-2019-thailand-abbreviated-malaria-operational-plan.pdf
  14. Price RN, von Seidlein L, Valecha N, Nosten F, Baird JK, White NJ. Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis. Lancet Infect Dis 2014; 14: 982-991. https://doi.org/10.1016/S1473-3099(14)70855-2.
  15. Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis 2009; 42: 267-278. https://doi.org/10.1016/j.bcmd.2008.12.005
  16. Boonyuen U, Songdej D, Tanyaratsrisakul S, Phuanukoonnon S, Chamchoy K, Praoparotai A, Pakparnich P, Sudsumrit S, Edwards T, Williams CT, Byrne RL, Adams ER, Imwong M. Glucose6-phosphate dehydrogenase mutations in malaria endemic area of Thailand by multiplexed high-resolution melting curve analysis. Malar J 2021; 20: 194. https://doi.org/10.1186/s12936-021-03731-0
  17. Charoenkwan P, Tantiprabha W, Sirichotiyakul S, Phusua A, Sanguansermsri T. Prevalence and molecular characterization of glucose-6-phosphate dehydrogenase deficiency in northern Thailand. Southeast Asian J Trop Med Public Health 2014; 45: 187-193.
  18. Jitueakul S, Buncherd H, Thawornpan P, Tun AW, Thanapongpichat S. Characterization of G6PD genotypes in G6PD deficiency patients from Suratthani Hospital, Thailand. JAMS 2018; 51: 66-71.
  19. Ninokata A, Kimura R, Samakkarn U, Settheetham-Ishida W, Ishida T. Coexistence of five G6PD variants indicates ethnic complexity of Phuket islanders, Southern Thailand. J Hum Genet 2006; 51: 424-428. https://doi.org/10.1007/s10038-006-0380-y
  20. Laosombat V, Sattayasevana B, Janejindamai W, Viprakasit V, Shirakawa T, Nishiyama K, Matsuo M. Molecular heterogeneity of glucose-6-phosphate dehydrogenase (G6PD) variants in the south of Thailand and identification of a novel variant (G6PD Songklanagarind). Blood Cells Mol Dis 2005; 34: 191-196. https://doi.org/10.1016/j.bcmd.2004.11.001
  21. Bancone G, Chu CS, Somsakchaicharoen R, Chowwiwat N, Parker DM, Charunwatthana P, White NJ, Nosten FH. Characterization of G6PD genotypes and phenotypes on the northwestern Thailand-Myanmar border. PLoS One. 2014; 9: e116063. https://doi.org/10.1371/journal.pone.0116063
  22. Kanchanavithayakul A, Prasittisa K, Kiat-Amornrak P, Chanda M, Kittiwatanasarn P, Nuchprayoon I, Cheepsunthorn CL. Prevalence of glucose 6-phosphate dehydrogenase deficiency and genetic mutations among karen and lao populations in thailand. Southeast Asian J Trop Med Public Health 2017; 48: 1308-1317.
  23. Sathupak S, Leecharoenkiat K, Kampuansai J. Prevalence and molecular characterization of glucose-6-phosphate dehydrogenase deficiency in the Lue ethnic group of northern Thailand. Sci Rep 2021; 11: 2956. https://doi.org/10.1038/s41598-021-82477-w
  24. Phompradit P, Kuesap J, Chaijaroenkul W, Rueangweerayut R, Hongkaew Y, Yamnuan R, Na-Bangchang K. Prevalence and distribution of glucose-6-phosphate dehydrogenase (G6PD) variants in Thai and Burmese populations in malaria endemic areas of Thailand. Malar J 2011; 10: 368. https://doi.org/10.1186/1475-2875-10-368
  25. Bonito B, Polrat Wilairatana P, Tangpukdee N, Muangnoicharoen S, Poovorawan K, Srivicha Krudsood S. Prevalence of glucose6-phosphate dehydrogenase deficiency among vivax malaria patients at the Hospital for Tropical Diseases, Thailand. Southeast Asian J Trop Med Public Health 2019; 50: 211-216.
  26. Khammanee T, Sawangjaroen N, Buncherd H, Tun AW, Thanapongpichat S. A LAMP-SNP assay detecting C580Y mutation in Pfkelch13 gene from clinically dried blood spot samples. Korean J Parasitol 2021; 59: 15-22. https://doi.org/10.3347/kjp.2021.59.1.15
  27. Khammanee T, Sawangjaroen N, Buncherd H, Tun AW, Thanapongpichat S. Molecular surveillance of Pfkelch13 and Pfmdr1 mutations in Plasmodium falciparum isolates from Southern Thailand. Korean J Parasitol 2019; 57: 369-377. https://doi.org/10.3347/kjp.2019.57.4.369
  28. Thanapongpichat S, Khammanee T, Sawangjaroen N, Buncherd H, Tun AW. Genetic diversity of Plasmodium vivax in clinical isolates from Southern Thailand using PvMSP1, PvMSP3 (PvMSP3alpha, PvMSP3beta) genes and eight microsatellite markers. Korean J Parasitol 2019; 57: 469-479. https://doi.org/10.3347/kjp.2019.57.5.469
  29. Schoone GJ, Oskam L, Kroon NC, Schallig HD, Omar SA. Detection and quantification of Plasmodium falciparum in blood samples using quantitative nucleic acid sequence-based amplification. J Clin Microbiol 2000; 38: 4072-5407. https://doi.org/10.1128/JCM.38.11.4072-4075.2000
  30. Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol Biochem Parasitol 1993; 58: 283-292. https://doi.org/10.1016/0166-6851(93)90050-8
  31. Iwagami M, Nakatsu M, Khattignavong P, Soundala P, Lorphachan L, Keomalaphet S, Xangsayalath P, Kawai S, Hongvanthong B, Brey PT, Kano S. First case of human infection with Plasmodium knowlesi in Laos. PLoS Negl Trop Dis 2018; 12: e0006244. https://doi.org/10.1371/journal.pntd.0006244
  32. Ainoon O, Yu YH, Amir Muhriz AL, Boo NY, Cheong SK, Hamidah NH. Glucose-6-phosphate dehydrogenase (G6PD) variants in Malaysian Malays. Hum Mutat 2003; 21: 101. https://doi.org/10.1002/humu.9103
  33. Yusoff NM, Shirakawa T, Nishiyama K, Ghazali S, Ee CK, Orita A, Abdullah WZ, Isa MN, Van Rostenberghe H, Matsuo M. Molecular heterogeneity of glucose-6-phosphate dehydrogenase deficiency in Malays in Malaysia. Int J Hematol 2002; 76: 149-152. https://doi.org/10.1007/BF02982577
  34. World Health Organization. Updating the WHO G6PD classification of variants and the International Classification of Diseases, 11th Revision (ICD-11). Malaria Policy Committee Meeting. Background document for Session 7. 2019 October 2-4; Geneva, Switzerland. https://www.who.int/malaria/mpac/mpac-october2019-session7-updating-G6PD-classification.pdf
  35. Lee J, Kim TI, Kang JM, Jun H, Le HG, Thai TL, Sohn WM, Myint MK, Lin K, Kim TS, Na BK. Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency among malaria patients in Upper Myanmar. BMC Infect Dis 2018; 18: 131. https://doi.org/10.1186/s12879-018-3031-y
  36. World Health Organization. Guide to G6PD Deficiency Rapid Diagnostic Testing to Support P. vivax Radical Cure. World Health Organization. Geneva, Switzerland. 2018. https://apps.who.int/iris/bitstream/handle/10665/272971/9789241514286-eng.pdf
  37. Huang Y, Choi MY, Au SW, Au DM, Lam VM, Engel PC. Purification and detailed study of two clinically different human glucose 6-phosphate dehydrogenase variants, G6PD(Plymouth) and G6PD(Mahidol): Evidence for defective protein folding as the basis of disease. Mol Genet Metab 2008; 93: 44-53. https://doi. org/10.1016/j.ymgme.2007.08.122
  38. Gomez-Manzo S, Terron-Hernandez J, De la Mora-De la Mora I, Gonzalez-Valdez A, Marcial-Quino J, Garcia-Torres I, VanoyeCarlo A, Lopez-Velazquez G, Hernandez-Alcantara G, OriaHernandez J, Reyes-Vivas H, Enriquez-Flores S. The stability of G6PD is affected by mutations with different clinical phenotypes. Int J Mol Sci 2014; 15: 21179-21201. https://doi.org/10.3390/ijms151121179
  39. Au SW, Gover S, Lam VM, Adams MJ. Human glucose-6-phosphate dehydrogenase: the crystal structure reveals a structural NADP(+) molecule and provides insights into enzyme deficiency. Structure 2000; 8: 293-303. https://doi.org/10.1016/s0969-2126(00)00104-0
  40. Kaplan JC. Defective molecular variants of glucose-6-phosphate dehydrogenase and methaemoglobin reductase. J Clin Pathol Suppl (R Coll Pathol) 1974; 8: 134-141. https://doi.org/10.1136/jcp.27.Suppl_8.134
  41. Piomelli S, Corash LM, Davenport DD, Miraglia J, Amorosi EL. In vivo lability of glucose-6-phosphate dehydrogenase in GdA-and GdMediterranean deficiency. J Clin Invest 1968; 47: 940-948. https://doi.org/10.1172/JCI105786
  42. Bancone G, Chu CS. G6PD Variants and haemolytic sensitivity to primaquine and other drugs. Front Pharmacol 2021; 12: 638885. https://doi.org/10.3389/fphar.2021.638885
  43. Khim N, Benedet C, Kim S, Kheng S, Siv S, Leang R, Lek S, Muth S, Chea N, Chuor CM, Duong S, Kerleguer A, Tor P, Chim P, Canier L, Witkowski B, Taylor WR, Menard D. G6PD deficiency in Plasmodium falciparum and Plasmodium vivax malaria-infected Cambodian patients. Malar J 2018; 12: 171. https://doi.org/10.1186/1475-2875-12-171
  44. Jiang W, Yu G, Liu P, Geng Q, Chen L, Lin Q, Ren X, Ye W, He Y, Guo Y, Duan S, Wen J, Li H, Qi Y, Jiang C, Zheng Y, Liu C, Si E, Zhang Q, Tian Q, Du C. Structure and function of glucose6-phosphate dehydrogenase-deficient variants in Chinese population. Hum Genet 2006; 119: 463-478. https://doi.org/10.1007/s00439-005-0126-5
  45. Wang J, Luo E, Hirai M, Arai M, Abdul-Manan E, Mohamed-Isa Z, Hidayah N, Matsuoka H. Nine different glucose-6-phosphate dehydrogenase (G6PD) variants in a Malaysian population with Malay, Chinese, Indian and Orang Asli (aboriginal Malaysian) backgrounds. Acta Med Okayama 2008; 62: 327-332. https://doi.org/10.18926/AMO/30966
  46. Lo E, Zhong D, Raya B, Pestana K, Koepfli C, Lee MC, Yewhalaw D, Yan G. Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia. Malar J 2019; 18: 340. https://doi.org/10.1186/s12936-019-2981-x
  47. Kitcharoen S, Dechyotin S, Khemtonglang N, Kleesuk C. Relationship among glucose-6-phosphate dehydrogenase (G-6-PD) activity, G-6-PD variants and reticulocytosis in neonates of northeast Thailand. Clin Chim Acta 2015; 442: 125-129. https://doi.org/10.1016/j.cca.2015.01.017
  48. Lopez C, Saravia C, Gomez A, Hoebeke J, Patarroyo MA. Mechanisms of genetically-based resistance to malaria. Gene 2010 467: 1-12. https://doi.org/10.1016/j.gene.2010.07.008
  49. Ayi K, Turrini F, Piga A, Arese P. Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait. Blood 2004; 104: 3364-3371. https://doi.org/10.1182/blood-2003-11-3820
  50. Udom C, Thanispong K, Manguin S, Chareonviriyaphap T, Fungfuang W. Trophic Behavior and species diversity of the Anopheles barbirostris Complex (Diptera: Culicidae) in Thailand. J Med Entomol 2021; 58: 2376-2384. https://doi.org/10.1093/jme/tjab067
  51. Chu CS, Bancone G, Soe NL, Carrara VI, Gornsawun G, Nosten F. The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis. Wellcome Open Res 2019; 4: 25. https://doi.org/10.12688/wellcomeopenres.15100.2
  52. Rueangweerayut R, Bancone G, Harrell EJ, Beelen AP, Kongpatanakul S, Mohrle JJ, Rousell V, Mohamed K, Qureshi A, Narayan S, Yubon N, Miller A, Nosten FH, Luzzatto L, Duparc S, Kleim JP, Green JA. Hemolytic potential of tafenoquine in female volunteers heterozygous for glucose-6-phosphate dehydrogenase (G6PD) deficiency (G6PD Mahidol Variant) versus G6PD-normal volunteers. Am J Trop Med Hyg 2017; 97: 702-711. https://doi.org/10.4269/ajtmh.16-0779
  53. Chu CS, Bancone G, Nosten F, White NJ, Luzzatto L. Primaquineinduced haemolysis in females heterozygous for G6PD deficiency. Malar J 2018; 17: 101. https://doi.org/10.1186/s12936-018-2248-y